Key result
KCNH2-L693P mutation impairs hERG maturation and leaves ~39% residual current in heterozygotes, supporting pathogenic classification.
Why the study?
Many KCNH2 variants identified by next-generation sequencing, including p.L693P, remain classified as variants of uncertain significance and require functional validation.
Does the KCNH2-L693P mutation impair hERG channel function compared to wild-type?
Does the KCNH2-L693P mutation impair hERG channel function compared to wild-type?
The KCNH2-L693P mutation impairs hERG maturation and function, supporting its reclassification from a variant of uncertain significance to pathogenic for Long QT Syndrome Type 2.
May support reclassification of KCNH2-L693P as pathogenic in LQTS2; leaves open human validation studies.
BACKGROUND: Congenital long QT syndrome (LQTS) is an inherited arrhythmia characterized by QT prolongation and increased risk of ventricular arrhythmias. Type 2 LQTS (LQT2) results from mutations in the KCNH2 gene encoding the hERG potassium channel. With the widespread use of next-generation sequencing, many KCNH2 variants have been identified but remain classified as variants of uncertain significance (VUS), including p.L693P, requiring functional validation. METHODS: A proband with recurrent syncope and prolonged QTc underwent whole-exome and family-based Sanger sequencing, which detected a heterozygous KCNH2-L693P mutation. HEK293 cells were transiently transfected with wild-type (WT) and/or mutant hERG plasmids. Western blotting, immunofluorescence, and whole-cell patch clamp were performed to assess protein maturation, trafficking, and channel kinetics. RESULTS: Western blot showed reduced levels of the 155 kDa mature hERG and accumulation of the 135 kDa immature form, consistent with trafficking defects. Immunofluorescence confirmed endoplasmic reticulum (ER) retention. Electrophysiology revealed complete current loss in homozygotes and ~39% residual WT current in heterozygotes, indicating dominant-negative-like suppression. The mutation shifted steady-state inactivation and delayed recovery. CONCLUSIONS: The KCNH2-L693P mutation impairs hERG maturation and function, supporting its reclassification from variants of uncertain significance (VUS) to pathogenic and providing evidence for improved clinical management.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2025) studied Congenital long QT syndrome (LQTS) (n=1). KCNH2-L693P mutation vs. Wild-type (WT) hERG was evaluated on Protein maturation, trafficking, and channel kinetics. The KCNH2-L693P mutation impairs hERG maturation and function, causing complete current loss in homozygotes and ~39% residual current in heterozygotes, supporting its pathogenic classification.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: